Balversa 3 mg, Filmtabletten - 56 Swissmedic Key 67660001 Registration Holder Janssen-Cilag AG Name Balversa 3 mg, Filmtabletten Date of registration 14.01.2025 Introduction of Sequence 14.01.2025 ATC-Classification (L01EN01) Revision date WHO WHO-DDD Valid until 13.01.2030 Index Therapeuticus (BSV) Show package size 56 Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680676600013 Medication Code Synthetika Pharmacode Disponibility
Composition erdafitinibum 3 mg, mannitolum, cellulosum microcristallinum, megluminum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, talcum, E 172 (flavum), glyceroli monocaprylocapras, natrii laurilsulfas, pro compresso obducto corresp. natrium 0.329 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Erdafitinibum 3 mg
Inactive agents additional_information (Flavum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Glyceroli Monocaprylocapras Magnesii Stearas Mannitol Meglumine Natrii Laurilsulfas Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Talcum
Source Data was imported : 07.02.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
